Gene therapy for inherited retinal diseases.
Ontology highlight
ABSTRACT: Inherited retinal diseases (IRDs) are a genetically variable collection of devastating disorders that lead to significant visual impairment. Advances in genetic characterization over the past two decades have allowed identification of over 260 causative mutations associated with inherited retinal disorders. Thought to be incurable, gene supplementation therapy offers great promise in treating various forms of these blinding conditions. In gene replacement therapy, a disease-causing gene is replaced with a functional copy of the gene. These therapies are designed to slow disease progression and hopefully restore visual function. Gene therapies are typically delivered to target retinal cells by subretinal (SR) or intravitreal (IVT) injection. The historic Food and Drug Administration (FDA) a
SUBMITTER: Nuzbrokh Y
PROVIDER: S-EPMC8421966 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA